Dupilumab becomes the first FDA-approved drug for Eosinophilic Esophagitis
Eosinophilic esophagitis (EoE) is an increasingly common inflammatory disorder in which immune cells called eosinophils infiltrate the esophagus. This...
dupilumab mechanism of action